The First Subject Has Been dosed In a Phase 2 Trial...

Max - 0

Electromedical Technologies Inc (OTCMKTS:EMED) Pioneers New Bioelectronic Medicine Path

Max - 0

Hepion Pharmaceuticals Inc (NASDAQ:HEPA) Completes The Study Of CRV431

Max - 0

Provention Bio Inc (NASDAQ:PRVB) Unveils Phase 2b PROACTIVE Study Of PRV-015

Max - 0

CorMedix Inc (NYSEAMERICAN:CRMD) Pleased About FDA’s Priority Review Of Its NDA

Max - 0

CohBar Inc. (NASDAQ:CWBR) Has Dosed the First Subjects with CB4211 in...

Max - 0

Results from Phase 2 Study of Vupanorsen (AKCEA-ANGPTL3-L (Rx)) by Akcea...

Max - 0

Moderna Inc. (NASDAQ:MRNA) is in talks with Japan to Sell 40...

Max - 0

OncoCyte Corp (NYSEAMERICAN:OCX) and the Guardian Research Network® Collaborate to Establish...

Max - 0

Orchard Therapeutics PLC – ADR (NASDAQ:ORTX) Makes Public Additional Interim Data...

Max - 0
1...192193194...248Page 193 of 248